Please try another search
For the fiscal year ended 31 December 2016, LombardMedical Inc revenues decreased 19% to $12.2M. Net lossdecreased 18% to $31M. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Lower net loss reflectsSelling, marketing and distribution expe decrease of 48% to$12M (expense), Administrative expenses decrease of 40% to$7M (expense).
Period Ending: | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
---|---|---|---|---|
Total Revenue | 2.4 | 3.04 | 3.8 | 2.92 |
Gross Profit | -0.61 | 0.35 | 0.41 | 0.98 |
Operating Income | -7.5 | -6.76 | -7.29 | -7.32 |
Net Income | -7.69 | -7.42 | -8.31 | -7.61 |
Period Ending: | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
---|---|---|---|---|
Total Assets | 67.77 | 64.14 | 68.34 | 76.85 |
Total Liabilities | 53.79 | 46.48 | 42.79 | 42 |
Total Equity | 13.97 | 17.66 | 25.55 | 34.85 |
Period Ending: | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
---|---|---|---|---|
Period Length: | 12 Months | 9 Months | 6 Months | 3 Months |
Cash From Operating Activities | -25.2 | -22.41 | -17.55 | -8.55 |
Cash From Investing Activities | -0.09 | -0.1 | -0.2 | -0.2 |
Cash From Financing Activities | 15.81 | 1.21 | -0.79 | -0.4 |
Net Change in Cash | -11.54 | -22.48 | -19.35 | -9.97 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review